Marché Fermé -
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
2,12 USD | +3,41% | +7,61% | +50,35% |
Métier
Nombre d'employés: 83
Ventes par activité
USD en Millions | 2022 | Poids | 2023 | Poids | Delta |
---|---|---|---|---|---|
Mental Health Innovations
100,0
%
| 0 | 100,0 % | 0 | 100,0 % | +34,76% |
Ventes par région
USD en Millions | 2022 | Poids | 2023 | Poids | Delta |
---|---|---|---|---|---|
United States and Germany
100,0
%
| 0 | 100,0 % | 0 | 100,0 % | +34,76% |
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Florian Brand
CEO | Chief Executive Officer | 37 | 01/06/18 |
Srinivas Rao
FOU | Founder | 55 | 01/06/18 |
Anne Johnson
DFI | Director of Finance/CFO | - | 01/01/21 |
Kevin Craig
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/21 |
Arvind Tewari
COO | Chief Operating Officer | 39 | 01/01/21 |
Frank Stegert
CIO | Chief Investment Officer | 41 | - |
Samantha Bender
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/21 |
Chief Tech/Sci/R&D Officer | 55 | 01/01/20 | |
Chris Lee
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/21 |
Michael Raven
COO | Chief Operating Officer | - | 01/01/22 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Sabrina Johnson
BRD | Director/Board Member | 57 | 01/01/21 |
Founder | 46 | 01/06/18 | |
Amir Kalali
BRD | Director/Board Member | 58 | - |
Andrea Smiley
BRD | Director/Board Member | 56 | 01/01/21 |
Jason Camm
BRD | Director/Board Member | 35 | 01/01/22 |
Michael Auerbach
BRD | Director/Board Member | 48 | 01/01/22 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 166 026 396 | 149 440 170 ( 90,01 %) | 0 | 90,01 % |
Participations
Nom | Actions | % | Valorisation |
---|---|---|---|
INTELGENX TECHNOLOGIES CORP. 21,36% | 37 300 000 | 21,36% | 6 564 800 $ |
Coordonnées société
Sociétés du groupe
Nom | Catégorie et Secteur |
---|---|
ATAI Life Sciences AG
ATAI Life Sciences AG Pharmaceuticals: MajorHealth Technology ATAI Life Sciences AG operates as a holding company, which is a global biotech company builder. The company was founded by Christian Angermayer, Lars Christian Wilde, Srinivas G. Rao and Florian Brand in 2018 and is headquartered in Munich, Germany. |
Pharmaceuticals: Major
|
Secteur
Révisions de BNA
Varia. 1 janv. | Capi. | |
---|---|---|
+50,35% | 343 M | |
+22,81% | 47,9 Md | |
+46,56% | 41,42 Md | |
-1,88% | 40,7 Md | |
-6,20% | 28,92 Md | |
+11,33% | 25,55 Md | |
-21,00% | 19,27 Md | |
-1,43% | 12,15 Md | |
+30,73% | 12,14 Md | |
-0,48% | 11,99 Md |
- Bourse
- Actions
- Action ATAI
- Société Atai Life Sciences N.V.